These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 28477708

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cholinergic transmission is impaired in patients with idiopathic normal-pressure hydrocephalus: a TMS study.
    Nardone R, Golaszewski S, Schwenker K, Brigo F, Maccarrone M, Versace V, Sebastianelli L, Saltuari L, Höller Y.
    J Neural Transm (Vienna); 2019 Aug; 126(8):1073-1080. PubMed ID: 31227893
    [Abstract] [Full Text] [Related]

  • 23. Short-latency afferent inhibition predicts verbal memory performance in patients with multiple sclerosis.
    Cucurachi L, Immovilli P, Granella F, Pavesi G, Cattaneo L.
    J Neurol; 2008 Dec; 255(12):1949-56. PubMed ID: 18854915
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Olfactory impairment predicts cognitive decline in early Parkinson's disease.
    Fullard ME, Tran B, Xie SX, Toledo JB, Scordia C, Linder C, Purri R, Weintraub D, Duda JE, Chahine LM, Morley JF.
    Parkinsonism Relat Disord; 2016 Apr; 25():45-51. PubMed ID: 26923521
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In vivo functional evaluation of central cholinergic circuits in vascular dementia.
    Di Lazzaro V, Pilato F, Dileone M, Profice P, Marra C, Ranieri F, Quaranta D, Gainotti G, Tonali PA.
    Clin Neurophysiol; 2008 Nov; 119(11):2494-500. PubMed ID: 18829384
    [Abstract] [Full Text] [Related]

  • 29. Olfactory tests in the diagnosis of essential tremor.
    Shah M, Muhammed N, Findley LJ, Hawkes CH.
    Parkinsonism Relat Disord; 2008 Nov; 14(7):563-8. PubMed ID: 18321760
    [Abstract] [Full Text] [Related]

  • 30. Short latency afferent inhibition differs among the subtypes of mild cognitive impairment.
    Nardone R, Bergmann J, Christova M, Caleri F, Tezzon F, Ladurner G, Trinka E, Golaszewski S.
    J Neural Transm (Vienna); 2012 Apr; 119(4):463-71. PubMed ID: 22016008
    [Abstract] [Full Text] [Related]

  • 31. Olfactory deficits and cognitive dysfunction in Parkinson's disease.
    Parrao T, Chana P, Venegas P, Behrens MI, Aylwin ML.
    Neurodegener Dis; 2012 Apr; 10(1-4):179-82. PubMed ID: 22343138
    [Abstract] [Full Text] [Related]

  • 32. Short-latency afferent inhibition as a biomarker of cholinergic degeneration compared to PET imaging in Parkinson's disease.
    d'Angremont E, Sommer IEC, van der Zee S, van Laar T, de Vries EFJ, Zijdewind I.
    Parkinsonism Relat Disord; 2024 Apr; 121():106032. PubMed ID: 38364622
    [Abstract] [Full Text] [Related]

  • 33. Cholinergic dysfunction in subcortical ischaemic vascular dementia: a transcranial magnetic stimulation study.
    Nardone R, Bergmann J, Tezzon F, Ladurner G, Golaszewski S.
    J Neural Transm (Vienna); 2008 May; 115(5):737-43. PubMed ID: 18188496
    [Abstract] [Full Text] [Related]

  • 34. Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease.
    Baba T, Takeda A, Kikuchi A, Nishio Y, Hosokai Y, Hirayama K, Hasegawa T, Sugeno N, Suzuki K, Mori E, Takahashi S, Fukuda H, Itoyama Y.
    Mov Disord; 2011 Mar; 26(4):621-8. PubMed ID: 21284041
    [Abstract] [Full Text] [Related]

  • 35. Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study.
    Nardone R, Florio I, Lochner P, Tezzon F.
    Exp Brain Res; 2005 May; 163(1):128-31. PubMed ID: 15754175
    [Abstract] [Full Text] [Related]

  • 36. Short and long latency afferent inhibition in Parkinson's disease.
    Sailer A, Molnar GF, Paradiso G, Gunraj CA, Lang AE, Chen R.
    Brain; 2003 Aug; 126(Pt 8):1883-94. PubMed ID: 12805105
    [Abstract] [Full Text] [Related]

  • 37. Cortical afferent inhibition reflects cognitive impairment in obstructive sleep apnea syndrome: a TMS study.
    Nardone R, Bergmann J, Brigo F, Höller Y, Schwenker K, Florea C, Kunz AB, Golaszewski S, Trinka E.
    Sleep Med; 2016 Aug; 24():51-56. PubMed ID: 27810186
    [Abstract] [Full Text] [Related]

  • 38. Specific intranasal and central trigeminal electrophysiological responses in Parkinson's disease.
    Tremblay C, Emrich R, Cavazzana A, Klingelhoefer L, Brandt MD, Hummel T, Haehner A, Frasnelli J.
    J Neurol; 2019 Dec; 266(12):2942-2951. PubMed ID: 31451911
    [Abstract] [Full Text] [Related]

  • 39. Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson's disease.
    Mao CJ, Wang F, Chen JP, Yang YP, Chen J, Huang JY, Liu CF.
    Clin Interv Aging; 2017 Dec; 12():1637-1644. PubMed ID: 29070942
    [Abstract] [Full Text] [Related]

  • 40. Olfactory dysfunctions in drug-naïve Parkinson's disease with mild cognitive impairment.
    Park JW, Kwon DY, Choi JH, Park MH, Yoon HK.
    Parkinsonism Relat Disord; 2018 Jan; 46():69-73. PubMed ID: 29233469
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.